Although the precise biological mechanisms underlying VDR gene involvement in MS remain fully elucidated, our analysis of the TaqI polymorphism (rs731236) revealed no significant differences in either genotypic or allelic frequencies between MS patients and controls. This evidence concerns the gene VDR and myeloid sarcoma.